Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

17.45
Delayed Data
As of Jul 31
 +0.39 / +2.29%
Today’s Change
7.20
Today|||52-Week Range
20.00
+10.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.0019.0K152.4K152.4K
 
 
 
 
Depreciation And Amortization0.00235.001.1K3.9K
 
 
 
 
 
Operating ExpensesGross Income0.00--------
General Expenses882.0K25.8M20.3M55.9M
 
 
 
 
 
Research And Development327.3K21.0M13.7M40.1M
 
 
 
 
 
Total Operating Expenses882.0K25.8M20.3M55.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-882.0K-25.8M-20.2M-55.7M
 
 
 
 
 
Extraordinary Credit0.001.7M3.3M720.0K
 
 
 
 
Extraordinary Charge0.00-1.1M-2.8M0.00
 
 
 
Interest Expense On Debt7.1K905.7K952.9K930.7K
 
 
 
 
 
Other Expenses0.00272.2K108.9K95.4K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-889.1K-25.9M-20.5M-55.8M
 
 
 
 
 
Income Taxes0.00-330.0K0.000.00
 
 
Minority Interest-36.0K-8.1M0.000.00
 
 
 
Net Income-853.1K-18.1M-20.5M-55.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.2K13.1M25.4M34.1M
 
 
 
 
 
Shares To Calculate EPS Diluted34.2K13.1M25.4M34.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$24.75-$1.38-$0.81-$1.64
 
 
 
 
 
EPS Diluted-$24.75-$1.38-$0.81-$1.64